Search hospitals > Arizona > Phoenix
Barrow Neurological Institute
Claim this profilePhoenix, Arizona 85013
Global Leader in Amyotrophic Lateral Sclerosis
Global Leader in Alzheimer's Disease
Conducts research for Parkinson's Disease
Conducts research for Epilepsy
Conducts research for Brain Tumor
160 reported clinical trials
16 medical researchers
Summary
Barrow Neurological Institute is a medical facility located in Phoenix, Arizona. This center is recognized for care of Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Parkinson's Disease, Epilepsy, Brain Tumor and other specialties. Barrow Neurological Institute is involved with conducting 160 clinical trials across 197 conditions. There are 16 research doctors associated with this hospital, such as Shafeeq S. Ladha, Anna Burke, Holly Shill, MD, and Jay Turner, MD.Area of expertise
1Amyotrophic Lateral Sclerosis
Global LeaderSOD1 negative
FUS negative
SOD1 positive
2Alzheimer's Disease
Global LeaderTrisomy 21 positive
Unbalanced translocation involving chromosome 21 positive
ApoE positive
Top PIs
Shafeeq S. LadhaBarrow Neurological Institute1 year of reported clinical research
Studies Amyotrophic Lateral Sclerosis
Studies Pompe Disease
6 reported clinical trials
6 drugs studied
Anna BurkeBarrow Neurological Institute6 years of reported clinical research
Studies Alzheimer's Disease
Studies Down Syndrome
5 reported clinical trials
8 drugs studied
Holly Shill, MDBarrow Neurological Institute4 years of reported clinical research
Studies Parkinson's Disease
Studies Parkinsonism
3 reported clinical trials
3 drugs studied
Jay Turner, MDBarrow Neurological Institute5 years of reported clinical research
Studies Scoliosis
Studies Sacroiliac Joint Dysfunction
2 reported clinical trials
3 drugs studied
Clinical Trials running at Barrow Neurological Institute
Parkinson's Disease
Alzheimer's Disease
Epilepsy
Amyotrophic Lateral Sclerosis
Scoliosis
Myasthenia Gravis
Kyphosis
Quadriplegia
Stroke
Vascular Dementia
CREXONT ER
for Parkinson's Disease
The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).
Recruiting3 awards Phase 42 criteria
Genetic Registry
for Parkinson's Disease
Development of a central repository for PD-related genomic data for future research.
Recruiting1 award N/A
Deep Phenotyping
for Parkinson's Disease
The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls. The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability.
Recruiting1 award N/A8 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Barrow Neurological Institute?
Barrow Neurological Institute is a medical facility located in Phoenix, Arizona. This center is recognized for care of Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Parkinson's Disease, Epilepsy, Brain Tumor and other specialties. Barrow Neurological Institute is involved with conducting 160 clinical trials across 197 conditions. There are 16 research doctors associated with this hospital, such as Shafeeq S. Ladha, Anna Burke, Holly Shill, MD, and Jay Turner, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.